Interventional Cardiology: Carotid Artery Stents and Embolic Protection Systems
Interventional Cardiology: Carotid Artery Stents and Embolic Protection Systems
$4,750.00
This medical market and technology report provides a comprehensive discussion of the global market for carotid artery stents and embolic protection systems. Geographically
Publisher: Meddevicetracker
- Description
- Contents
Overview
Ischemic stroke remains a leading cause of death worldwide, with nearly 10 million new cases per year and a prevalence of more than 75 million. Carotid artery stenting (CAS) is a less-invasive treatment compared to open surgery and extends treatment to a wider group of patients including those who are poor candidates for open surgery. Embolic protection plays an important role in a CAS procedure, and most CAS manufacturers have developed embolic protection devices (EPDs) for use in conjunction with their CAS systems. In 2020, the global market for CAS systems and EPDs totaled nearly $350m. During the forecast period covered by this report, total sales are projected to expand at a CAGR of more than 9%, exceeding $530m in 2025. 2020 sales reflect a significant drop over 2019, as the COVID-19 pandemic had a profound impact on procedure volumes in the first half of 2020. A large boost is expected in 2021, with a return to more typical market patterns for the remainder of the forecast period. The leading suppliers of CAS systems and EPDs include Abbott and Silk Road Medical, with nearly 70% of the market combined. Other suppliers include Cordis, Medtronic, and Boston Scientific. This analysis provides a clinical overview and prevalence data for carotid artery stenosis, product portfolios offered by leading manufacturers as well as emerging products, and in-depth market and competitive analyses of the CAS system and EPD markets. Forecasts are provided for 2020–25 for the US, five major European markets (France, Germany, Italy, Spain, and the UK), Japan, and Rest of World markets.
The report provides the following useful information:
- clinical overview of carotid artery stenosis, screening guidelines, and treatments
- prevalence data for carotid artery stenosis
- product portfolios offered by leading manufacturers
- top-selling devices, as well as emerging products
- in-depth market and competitive analyses.
Table of Contents
Executive Summary …………………………………………………………………….. ES-1
i. Market forecast……………………………………………………………………………………………… ES-1
a. Market leaders ………………………………………………………………………………….. ES-3
ii. Methodology………………………………………………………………………………………………… ES-3
iii. Bibliography ………………………………………………………………………………………………… ES-5
Exhibit ES-1: Carotid artery stents and embolic protection devices, market forecast, by country/region ($m), 2020–25………………………………………………………………….. ES-2
1. Clinical Overview ………………………………………………………………………1-1
1.1 Ischemic stroke ……………………………………………………………………………………………..1-1
1.2 Stroke incidence and prevalence ………………………………………………………………………1-3
1.3 Carotid artery stenosis ……………………………………………………………………………………1-4
1.3.1 Prevalence………………………………………………………………………………………1-4
1.3.2 Screening guidelines…………………………………………………………………………1-5
1.3.3 Treatment……………………………………………………………………………………….1-6
1.4 Bibliography………………………………………………………………………………………………..1-14
Exhibit 1-1: Clinical features and characteristics of ischemic stroke ………………………………1-2
Exhibit 1-2: Ischemic stroke, incidence in selected countries, by gender, 2019 ……………….1-4
Exhibit 1-3: Carotid endarterectomy procedure ………………………………………………………..1-7
Exhibit 1-4: Carotid artery stenting procedure…………………………………………………………..1-9
Exhibit 1-5: Guidelines for treatment of symptomatic and asymptomatic carotid artery stenosis……………………………………………………………………………..1-10
2. Carotid Artery Stents and Embolic Protection Devices………………………2-1
2.1 Carotid artery stents……………………………………………………………………………………….2-1
2.1.1 Emerging products……………………………………………………………………………2-6
2.2 Embolic protection devices………………………………………………………………………………2-6
2.3 Bibliography………………………………………………………………………………………………..2-12
Exhibit 2-1: Selected carotid artery stents, 2021………………………………………………………..2-3
Exhibit 2-2: Abbott’s RX Acculink carotid artery stent system………………………………………2-5
Exhibit 2-3: Terumo’s Roadsaver carotid artery stent system ………………………………………2-6
Exhibit 2-4: Advantages and disadvantages of embolic protection devices in carotid artery stenting……………………………………………………………………………….2-8
Exhibit 2-5: Selected embolic protection devices, 2021 ………………………………………………2-9
Exhibit 2-6: Abbott’s RX Accunet embolic protection system……………………………………..2-10
Exhibit 2-7: Medtronic’s SpiderFX embolic protection system ……………………………………2-11
3. Carotid Artery Stents and Embolic Protection Devices Market…………….3-1
3.1 Combined market forecast………………………………………………………………………………3-1
3.1.1 Sales by country/region …………………………………………………………………….3-6
3.1.2 Sales by product segment ………………………………………………………………….3-7
3.2 Combined competitive analysis………………………………………………………………………..3-7
3.3 Carotid artery stents……………………………………………………………………………………….3-8
3.3.1 Market forecast ……………………………………………………………………………….3-9
3.3.2 Competitive analysis……………………………………………………………………….3-13
3.4 Embolic protection devices…………………………………………………………………………….3-15
3.4.1 Market forecast ……………………………………………………………………………..3-15
3.4.2 Competitive analysis……………………………………………………………………….3-18
3.5 Bibliography………………………………………………………………………………………………..3-20
Exhibit 3-1: Carotid artery stents and embolic protection devices, market forecast, by country/region ($m), 2020–25 ………………………………………………………………..3-5
Exhibit 3-2: Carotid artery stents and embolic protection devices, sales by country/region, 2020……………………………………………………………………..3-6
Exhibit 3-3: Carotid artery stents and embolic protection devices, market forecast, by product segment ($m), 2020–25……………………………………………………………..3-7
Exhibit 3-4: Carotid artery stents and embolic protection devices market, share by supplier, 2020 ……………………………………………………………………………..3-8
Exhibit 3-5: Carotid artery stents, market forecast, by country/region ($m), 2020–25……3-10
Exhibit 3-6: Carotid artery stents market, share by country/region, 2020…………………….3-11
Exhibit 3-7: Carotid artery stenting, procedure volumes forecast, by country/region, 2020–25 ……………………………………………………………………..3-12
Exhibit 3-8: Carotid artery stenting, procedure volumes, share by country/region, 2020…………………………………………………………………..3-13
Exhibit 3-9: Carotid artery stents market, share by supplier, 2020………………………………3-15
Exhibit 3-10: Embolic protection devices, market forecast, by country/region ($m), 2020–25 ………………………………………………………………3-17
Exhibit 3-11: Embolic protection devices market, share by country/region, 2020 ………….3-18
Exhibit 3-12: Embolic protection devices market, share by supplier, 2020……………………3-19
Appendix: Company Listing……………………………………………………………. A-1
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Disease Analysis: HR+/HER2- Breast Cancer 
Sign up to the